The global COVID-19 treatment divide.

Usher, Ann Danaiya

Usher, Ann Danaiya.

Lancet ; 399(10327): 779-782, 2022 02 26.

Article in En | MEDLINE | ID: mdl-35219388

Subject(s)

COVID-19 Drug Treatment; COVID-19 Testing/standards; Health Services Accessibility; Lactams; Leucine; Nitriles; Proline; Ritonavir; COVID-19 Testing/statistics & numerical data; Developing Countries; Drug Combinations; Global Health; Humans; Lactams/supply & distribution; Lactams/therapeutic use; Leucine/supply & distribution; Leucine/therapeutic use; Nitriles/supply & distribution; Nitriles/therapeutic use; Proline/supply & distribution; Proline/therapeutic use; Ritonavir/supply & distribution; Ritonavir/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proline / Ritonavir / COVID-19 Testing / COVID-19 Drug Treatment / Health Services Accessibility / Lactams / Leucine / Nitriles Aspects: Determinantes_sociais_saude Limits: Humans Language: En Journal: Lancet Year: 2022 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google